Clinical Trial

Unveiling Patient Experiences in Testicular Cancer Clinical Trials

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2023 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical research participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about testicular cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with testicular cancer who are invited to take part in medical research will benefit from the analysis of the data.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05928377
Lead Sponsor Power Life Sciences Inc.
Conditions Testicular Cancer
Enrollment 500 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2023-07-03